156731-40-7

Basic information

• Product Name: Carbamic acid, 3-butenyl-, 1,1-dimethylethyl ester (9CI)
• Synonyms: TERT-BUTYL BUT-3-ENYLCARBAMATE;tert-butyl but-3-en-1-ylcarbaMate;But-3-enyl-carbaMic acid tert-butyl ester;1-(Boc-amino)-3-butene;Boc-4-amino-1-butene;But-3-en-1-amine,N-BOCprotected;tert-Butyl N-but-3-enylcarbamate;N-Boc-but-3-en-1-amine
• CAS NO: 156731-40-7
• Molecular Formula: C₉H₁₇NO₂
• Molecular Weight: 171.23678
• Product Categories: N-BOC
• Mol File: 156731-40-7.mol
• Article Data: 30

Chemical Properties

• Boiling Point: 237.9±19.0 °C(Predicted)
• Flash Point: 101℃
• Appearance: /
• Density: 0.929 g/mL at 25 °C
• Refractive Index: n20/D1.443
• Storage Temp.: 2-8°C
• PKA: 12.80±0.46(Predicted)
• CAS DataBase Reference: Carbamic acid, 3-butenyl-, 1,1-dimethylethyl ester (9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: Carbamic acid, 3-butenyl-, 1,1-dimethylethyl ester (9CI)(156731-40-7)
• EPA Substance Registry System: Carbamic acid, 3-butenyl-, 1,1-dimethylethyl ester (9CI)(156731-40-7)

Safety Data

• Hazard Codes: Xn,N
• Statements: 22-50
• Safety Statements: 61
• RIDADR: UN 3082 9 / PGIII
• WGK Germany: 3
• Hazardous Substances Data: 156731-40-7(Hazardous Substances Data)

Usage

General Description

Carbamic acid, 3-butenyl-, 1,1-dimethylethyl ester (9CI) is a chemical compound that falls under the category of carbamate esters. It is commonly used as an intermediate in the synthesis of various pharmaceuticals and agrochemicals. Carbamic acid, 3-butenyl-, 1,1-dimethylethyl ester (9CI) is also known for its use as a reagent in organic synthesis. It is a colorless liquid with a distinct odor, and it is considered to be stable under normal temperatures and pressures. However, it is important to handle this chemical with caution as it may be hazardous if not used properly.

Upstream product

• 24424-99-5 di-tert-butyl dicarbonate 
• 17875-18-2 but-3-en-1-amine hydrochloride 
• 2524-49-4 3-butene-1-amine 
• 245507-96-4 C₉H₁₅ClMg 
• 1234576-81-8 3-iodo-pyrrolidine-1-carboxylic acid tert-butyl ester 
• 103057-44-9 N-(tert-butoxycarbonyl)-3-hydroxypyrrolidine 
• 27219-07-4 5-(N-tert-butyloxycarbonyl)aminopentanoic acid 
• 591-80-0 pent-4-enoic acid 
• 75-65-0 tert-butyl alcohol 
• 52114-85-9 4-isocyanatobut-1-ene 
• 71872-03-2 tert-Butyl-carbamic acid tert-butyl ester 
• 51779-32-9 iminodicarboxylic acid di-tert-butyl ester 
• 470443-12-0 di-tert-butyl N-3-butenyliminodicarboxylate 
• 113738-20-8 4-azido-1-butene 

Downstream Products

• 862498-72-4 methyl (2S,4E/Z)-2-(benzyloxycarboxamido)-7-(tert-butoxycarboxamido)-4-heptenoate 
• 1160722-70-2 tert-butyl (E)-1-(methoxycarbonyl)-3-phenylallylbut-3-enylcarbamate 
• 17150-61-7 N-(but-3-en-1-yl)benzamide 

Relevant articles and documents

DEOXYNOJIRIMYCIN DERIVATIVES AS GLUCOSIDASE INHIBITORS

The present invention relates to novel iminosugars and their use as glucosidase inhibitors. The present inventors discovered that certain deoxynojirimycin derivatives may be effective in inhibiting glucosidases. In particular, such deoxynojirimycin derivatives may be useful for treating a disease or condition in which inhibition of glucosidase may play an important role.

Design and Optimization of an Acyclic Amine Series of TRPV4 Antagonists by Electronic Modulation of Hydrogen Bond Interactions

Investigation of TRPV4 as a potential target for the treatment of pulmonary edema associated with heart failure generated a novel series of acyclic amine inhibitors displaying exceptional potency and PK properties. The series arose through a scaffold hopp

D3 RECEPTOR AGONIST COMPOUNDS; METHODS OF PREPARATION; INTERMEDIATES THEREOF; AND METHODS OF USE THEREOF

Disclosed herein are novel compounds including dopamine D3 receptor agonists, compositions thereof, methods of use thereof, and processes of synthesizing the same. Further disclosed are D3R selective agonist compounds, specifically bitopic ligands comprising chirality.